Sevoflurane Sedation in Patients With Septic Shock
Key facts
- Who runs it
- University of Zurich
- Where
- Switzerland4 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 153 people, planned
- Started
- Jan 2026
- Expected to end
- Nov 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Sevoflurane
- Control Group
- Record updated
- 1 April 2025
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Male and female patients, age 18 to 80 years
- Intensive care Unit (ICU) patients with septic shock (despite fluid resuscitation vasopressors needed to maintain mean arterial pressure ≥65 millimeter of mercury (mmHg), and serum lactate >2mmol/l even with fluid application)
- Treatment of septic shock on ICU with vasopressors not longer than 12 hours
- Sedation and mechanical ventilation on ICU
- Female patients of childbearing potential with negative pregnancy test
- Informed Consent as documented by signature
Who cannot take part
- Previous surgery and/or anesthesia (within last 7 days)
- Systemic corticosteroids in the phase before hospitalization (> 10mg/d prednisone)
- Significant concomitant disease (acute cerebral vascular event, acute coronary syndrome, decompensated heart failure, acute pulmonary edema, major cardiac arrhythmia, seizure, burn, chronic kidney disease, end stage liver failure, neuromuscular disease)
- Organ transplant
- Subject with active malignancy receiving
- chemotherapy or radiation treatment within last 60 days
- Anti-tumor necrosis factor (TNF) therapy
- Enrollment in any other clinical trial during the course of this trial, 30 days prior to its beginning or 30 days after its completion
- Suspected or known intolerance by history to volatile anesthetics (malignant hyperthermia)
- Autoimmune disease
- Hepatitis B/C virus infection
- Application of nitric oxide (NO)
- Immunosuppressive agents
- AIDS
- Pregnancy and/or Breast feeding
- Use of cytokine absorber
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Recent in vivo studies from others as well as the investigators group demonstrated that volatile anesthetics immunomodulate sepsis and improve outcome. Also, several clinical trials have convincingly shown that application of a volatile anesthetic provides protection in patients undergoing major surgery.
Read full original descriptionShow less
Patients with sepsis are intubated and ventilated and therefore need sedation. So far, most ICU centers use intravenously applied sedatives in these patients. In the proposed study, we will switch sedation from an intravenous to a volatile anesthetic for a short period of time to explore if sepsis markers improve within the following 120 hours upon sevoflurane conditioning.
The 2 groups in the trial
- Sevoflurane SedationTreatment being tested
Patients randomized into experimental group will be treated with sevoflurane during 4 hours
Treatment: Sevoflurane
- Propofol SedationExisting treatment, for comparison
Patients randomized into Control Group will get continued intravenous sedation with propofol
Treatment: Control Group
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Sevoflurane Sedation: A Potentially Promising Immunomodulation in Patients With Septic Shock
- Fit questions
- Built from NCT03643367, who can take part
- Record updated
- 1 April 2025